Seldon Capital’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-254
Closed -$140K 230
2022
Q4
$140K Hold
254
0.12% 57
2022
Q3
$129K Hold
254
0.09% 61
2022
Q2
$138K Hold
254
0.08% 62
2022
Q1
$150K Hold
254
0.09% 66
2021
Q4
$169K Buy
+254
New +$159K 0.11% 72

Other funds holding TMO

Seldon Capital's TMO Position: Q1 2023 in Review

Seldon Capital sold out of Thermo Fisher Scientific (TMO) in Q1 2023, closing a stake of 254 shares — an estimated $140K sold.

Seldon Capital first reported a position in TMO in Q4 2021 and held it in 5 quarters. The position peaked at $169K in Q4 2021. 2,387 funds tracked by Wall St. Rank hold TMO as of Q1 2023.

  • Seldon Capital reported no remaining Thermo Fisher Scientific position as of Q1 2023 after selling out during the quarter.
  • Seldon Capital sold 254 Thermo Fisher Scientific shares in Q1 2023, an estimated $140K.
  • Seldon Capital first reported a position in Thermo Fisher Scientific in Q4 2021 and held it in 5 quarters.
  • Seldon Capital's Thermo Fisher Scientific position peaked at $169K in Q4 2021.
  • 2,387 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2023.

Based on Seldon Capital's 13F filing for Q1 2023, filed 12 May 2023.